1.
Plant Biotechnol J
; 12(6): 651-4, 2014 Aug.
Artículo
en Inglés
| MEDLINE
| ID: mdl-24735114
RESUMEN
The development and marketing of 'novel' genetically modified (GM) crops in which composition has been deliberately altered poses a challenge to the European Union (EU)'s risk assessment processes, which are based on the concept of substantial equivalence with a non-GM comparator. This article gives some examples of these novel GM crops and summarizes the conclusions of a report that was commissioned by the European Food Safety Authority on how the EU's risk assessment processes could be adapted to enable their safety to be assessed.